SFX by Ex Libris Inc.

Title:	HIV-1 diversity and vaccine development
Source:	Science [0036-8075] Nabel, G yr:2002

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Akpogheneta, O. "Correlates of protection and HIV vaccine development." The Lancet infectious diseases 11.11 (2011): 814-815.
description	2.	Gaschen, Brian, B. "Diversity Considerations in HIV-1 Vaccine Selection." Science 296.5577 (2002): 2354-2360.
description	3.	Colantoni, A. "Dose-dependent effect of ethanol on hepatic oxidative stress and interleukin-6 production after burn injury in the mouse." Alcoholism: clinical and experimental research 24.9 (2000): 1443-1448.
description	4.	"Back Matter." Science 294.5549 (2001): 1970-2004.
description	5.	Martinez-Picado, J. "Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus." The Journal of experimental medicine 203.3 (2006): 529-539.
description	6.	Girard, Marc P P. "A review of vaccine research and development: the human immunodeficiency virus (HIV)." Vaccine 24.19 (2006): 4062-81.
description	7.	Taylor, Barbara S S. "The challenge of HIV-1 subtype diversity." New England Journal of Medicine, The 358.15 (2008): 1590-602.
description	8.	McMichael, A J J. "Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya." Nature medicine 6.9 (2000): 951-5.
description	9.	Anon.. "Back to basics for HIV vaccine development." Nature 452.7187 (2008): 516-516.
description	10.	Douek, Daniel C C. "The rational design of an AIDS vaccine." Cell 124.4 (2006): 677-81.
description	11.	Li, F. "Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation." Vaccine 24.47-48 (2006): 6893-904.
description	12.	"Front Matter." The American journal of nursing 93.9 (1993): 1-94.
description	13.	Myles, Brenda S. "Back Matter." Publications of the Modern Language Association of America 115.6, (2000): 1705-1888.
description	14.	Kalish, M L L. "The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials." AIDS 9.8 (1995): 851-7.
description	15.	Barouch, Dan H H. "Challenges in the development of an HIV-1 vaccine." Nature 455.7213 (2008): 613-9.
description	16.	Astrid K N Iversen Guillaume Stewart-Jones Gerald, Astrid K N K. "Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope." Nature immunology 7.2: 179-89.
description	17.	Mack, M. "Heritable breast cancer in twins." The British journal of cancer 87.3 (2002): 294-300.
description	18.	Choisy, M. "Comparative Study of Adaptive Molecular Evolution in Different Human Immunodeficiency Virus Groups and Subtypes." Journal of virology 78.4 (2004): 1962-1970.
description	19.	Bagla, Pallava, P. "New Vaccine Strategy." Science 319.5861 (2008): 269-269.
description	20.	Manrique, M.. "DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory." AIDS research and human retroviruses 24.3 (2008): 505-519.